Earnings Feed
Sign Up
Home/Insiders/MARCEL GEORGES ANTHONY
MG
SEC Insider//CIK 0001212645

MARCEL GEORGES ANTHONY

CIK 00012126452 companiesPARIS, FRANCE, I0
SEC Profile

Transactions

42

Companies

2

Filings

1

CIK

0001212645

Recent Transactions

42 trades
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.25/sh+7,500→ 18,750 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.40/sh−13,905→ 36,095 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−11,250→ 3,750 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.42/sh−5,000→ 0 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.90/sh+10,000→ 43,750 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.02/sh+6,250→ 50,000 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.32/sh−5,795→ 6,895 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−10,000→ 10,000 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.75/sh+11,250→ 11,250 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.37/sh−3,064→ 27,393 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−6,250→ 13,750 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.36/sh−1,500→ 25,893 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−15,000→ 5,000 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.35/sh−6,305→ 19,588 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.33/sh−6,898→ 12,690 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.38/sh−1,895→ 5,000 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−7,500→ 2,500 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.88/sh+15,000→ 33,750 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.39/sh−5,638→ 30,457 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.36/sh−1,500→ 25,893 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.75/sh+11,250→ 11,250 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.33/sh−6,898→ 12,690 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−7,500→ 2,500 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.35/sh−6,305→ 19,588 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.38/sh−1,895→ 5,000 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−10,000→ 10,000 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.90/sh+10,000→ 43,750 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.42/sh−5,000→ 0 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.40/sh−13,905→ 36,095 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−6,250→ 13,750 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.02/sh+6,250→ 50,000 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.39/sh−5,638→ 30,457 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.37/sh−3,064→ 27,393 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−15,000→ 5,000 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.25/sh+7,500→ 18,750 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-05-25$1.88/sh+15,000→ 33,750 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-05-25$3.32/sh−5,795→ 6,895 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-05-25−11,250→ 3,750 total
  • Award
    Aceragen, Inc.

    Stock Options

    2004-01-01+3,750→ 3,750 total
  • Award
    Aceragen, Inc.

    Stock Options

    2004-01-01+3,750→ 3,750 total
  • Award
    Aceragen, Inc.

    Stock Options

    2003-10-01+3,750→ 3,750 total
  • Award
    Aceragen, Inc.

    Stock Options

    2003-10-01+3,750→ 3,750 total

Companies

2

Recent Filings

1

Address

C/O TMC - DEVELOPMENT 10, RUE MESNIL

PARIS, FRANCE, I0, 75116

View on SEC.gov